BR9607234A - Grânulos mucoadesivos uso dos mesmos processo para sua preparação composição farmâceutica e uso da mesma - Google Patents

Grânulos mucoadesivos uso dos mesmos processo para sua preparação composição farmâceutica e uso da mesma

Info

Publication number
BR9607234A
BR9607234A BR9607234A BR9607234A BR9607234A BR 9607234 A BR9607234 A BR 9607234A BR 9607234 A BR9607234 A BR 9607234A BR 9607234 A BR9607234 A BR 9607234A BR 9607234 A BR9607234 A BR 9607234A
Authority
BR
Brazil
Prior art keywords
preparation
pharmaceutical composition
same process
mucoadhesive granules
granules
Prior art date
Application number
BR9607234A
Other languages
English (en)
Inventor
Peter William Dettmar
Paul Andrew Dickson
Frank Chadwick Hampson
Ian Gordon Jolliffe
William Peers
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of BR9607234A publication Critical patent/BR9607234A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Dental Preparations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9607234A 1995-03-13 1996-03-05 Grânulos mucoadesivos uso dos mesmos processo para sua preparação composição farmâceutica e uso da mesma BR9607234A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9505032.4A GB9505032D0 (en) 1995-03-13 1995-03-13 Improvements in or relating to organic compositions
PCT/GB1996/000514 WO1996028141A1 (en) 1995-03-13 1996-03-05 Improvements in or relating to organic compositions

Publications (1)

Publication Number Publication Date
BR9607234A true BR9607234A (pt) 1997-11-11

Family

ID=10771122

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9607234A BR9607234A (pt) 1995-03-13 1996-03-05 Grânulos mucoadesivos uso dos mesmos processo para sua preparação composição farmâceutica e uso da mesma

Country Status (21)

Country Link
US (1) US6306789B1 (pt)
EP (1) EP0814771B1 (pt)
JP (1) JPH11501652A (pt)
KR (1) KR19980702970A (pt)
CN (1) CN1126533C (pt)
AT (1) ATE212539T1 (pt)
AU (1) AU712464B2 (pt)
BR (1) BR9607234A (pt)
CZ (1) CZ274497A3 (pt)
DE (1) DE69618934T2 (pt)
ES (1) ES2167546T3 (pt)
GB (2) GB9505032D0 (pt)
HK (1) HK1011291A1 (pt)
HU (1) HUP9900800A3 (pt)
MX (1) MX9706992A (pt)
NO (1) NO974194L (pt)
NZ (1) NZ302741A (pt)
PL (1) PL184407B1 (pt)
TR (1) TR199700943T1 (pt)
WO (1) WO1996028141A1 (pt)
ZA (1) ZA962012B (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU736951C (en) * 1998-03-19 2003-02-20 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
GB9809347D0 (en) * 1998-05-05 1998-07-01 Reckitt & Colmann Prod Ltd Compositions
IN190017B (pt) * 1999-01-25 2003-05-31 Panacea Biotech Ltd
EP1347748A2 (en) 2000-12-05 2003-10-01 MacGregor, Alexander Hydrostatic delivery system for controlled delivery of agent
AU2002319653A1 (en) * 2001-07-20 2003-03-03 Samir Mitragotri Method for oral drug delivery
US6572889B1 (en) * 2002-03-07 2003-06-03 Noveon Ip Holdings Corp. Controlled release solid dosage carbamazepine formulations
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US8679545B2 (en) * 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US20120027855A1 (en) 2007-07-06 2012-02-02 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
WO2009008006A2 (en) * 2007-07-06 2009-01-15 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
EP2942053A1 (en) 2007-07-06 2015-11-11 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
US8865692B2 (en) * 2007-11-13 2014-10-21 Meritage Pharma, Inc Compositions for the treatment of gastrointestinal inflammation
EP3354276B1 (en) * 2007-11-13 2020-01-01 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
CA2721927C (en) 2008-04-21 2014-01-28 Otonomy, Inc. Auris formulations for treating otic diseases and conditions
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
US10092580B2 (en) 2008-07-21 2018-10-09 Otonomy, Inc. Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
US8784870B2 (en) * 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
EP3834819A1 (en) 2008-08-20 2021-06-16 The Regents of the University of California Corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
AU2014237970B2 (en) * 2013-03-15 2017-01-05 Cook Medical Technologies Llc Adhesive medical products and methods for treating gastrointestinal lesions
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
EP3328898B8 (en) 2015-07-28 2024-04-10 6452728 Canada Corp. Trkb or trkc agonist compositions and methods for the treatment of otic conditions
JP7033789B2 (ja) 2016-06-29 2022-03-11 オトノミー，インク． トリグリセリド耳用製剤とその使用
WO2019067680A1 (en) 2017-09-27 2019-04-04 Cook Medical Technologies Llc CROSSLINKING SUBMUCOSAL INJECTION SYSTEM
KR20200108873A (ko) 2018-01-09 2020-09-21 오토노미, 인코포레이티드 성장 인자 귀 제제
WO2019154895A1 (en) 2018-02-08 2019-08-15 Strekin Ag Gel formulation for preventing or treating hearing loss
CN114904007B (zh) * 2022-04-24 2024-04-05 南京紫鸿生物科技有限公司 一种提高卡波姆的堆积密度的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60237054A (ja) 1984-05-10 1985-11-25 Nippon Kayaku Co Ltd アミノ酸の晶析法
GB8428952D0 (en) 1984-11-16 1984-12-27 Beecham Group Plc Formulations
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
US5057317A (en) 1987-03-24 1991-10-15 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
EP0297866A3 (en) 1987-07-01 1989-12-13 The Boots Company PLC Therapeutic agents
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
DE4036757A1 (de) * 1990-11-17 1992-05-21 Bayer Ag Antazida-zubereitung mit verlaengerter magenverweilzeit
TW209174B (pt) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
US5350584A (en) * 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
EP0642797B1 (en) * 1993-09-09 2000-05-17 Takeda Chemical Industries, Ltd. Formulation comprising antibacterial substance and antiulcer substance

Also Published As

Publication number Publication date
EP0814771A1 (en) 1998-01-07
PL184407B1 (pl) 2002-10-31
GB9604678D0 (en) 1996-05-01
MX9706992A (es) 1997-11-29
GB2298790A (en) 1996-09-18
PL322065A1 (en) 1998-01-05
GB9505032D0 (en) 1995-05-03
DE69618934T2 (de) 2002-09-12
ZA962012B (en) 1996-09-26
NZ302741A (en) 1999-08-30
CZ274497A3 (cs) 1998-03-18
KR19980702970A (ko) 1998-09-05
HUP9900800A2 (hu) 1999-07-28
GB2298790B (en) 1999-06-30
AU4886896A (en) 1996-10-02
AU712464B2 (en) 1999-11-04
HUP9900800A3 (en) 2001-02-28
HK1011291A1 (en) 1999-07-09
EP0814771B1 (en) 2002-01-30
CN1126533C (zh) 2003-11-05
CN1178458A (zh) 1998-04-08
ATE212539T1 (de) 2002-02-15
WO1996028141A1 (en) 1996-09-19
US6306789B1 (en) 2001-10-23
NO974194D0 (no) 1997-09-11
ES2167546T3 (es) 2002-05-16
DE69618934D1 (de) 2002-03-14
JPH11501652A (ja) 1999-02-09
TR199700943T1 (xx) 1998-02-21
NO974194L (no) 1997-09-11

Similar Documents

Publication Publication Date Title
BR9607234A (pt) Grânulos mucoadesivos uso dos mesmos processo para sua preparação composição farmâceutica e uso da mesma
AU725283B2 (en) Bioadhesive pharmaceutical composition for the controlled release of active principles
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
EP1287822A3 (en) Mesalazine controlled release oral pharmaceutical compositions
CA2232855A1 (en) Pharmaceutical formulation
NO20001567D0 (no) Bioadhesive sammensetninger og fremgangsmåter for topisk administrering av aktive midler
CA2342340A1 (en) New sustained release oral formulations
DE69732412D1 (de) Polares bukkales spray
WO2002053100A3 (en) Pharmaceutical dosage form for oral administration of low molecular weight heparin
CA2131350A1 (en) Sustained release drug formulation containing a tramadol salt
AU1227899A (en) Osmotic medicament releasing system
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
CA2326198A1 (en) Cosolvent formulations
EP0966966A3 (en) Nefazodone dosage form
BR9607410A (pt) Soluções farmacêuticas salinas não inorgânicas para administração endonasal
CY1105168T1 (el) Διφασικη συνθεση με τραμαδολη
SE9603480D0 (sv) Beredningsform för svårlösliga läkemedel
WO2003041656A3 (en) Soluble drug extended release system
CA2244357A1 (en) A novel pharmaceutical composition for inhalation containing cr 2039 (andolast)
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
MXPA02006034A (es) Formas de dosis mucosaloral de apomorfina.
IT1263222B (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
DK0742716T3 (da) Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid
CA2214979A1 (en) Improvements in or relating to organic compositions
CO4910116A1 (es) Formulacion de liberacion controlada para farmacos basicos escasamente solubles

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B25D Requested change of name of applicant approved
B25G Requested change of headquarter approved
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 05/03/2016